Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
Clinical trial NCT01232062 · COMPLETED
Trial details
- NCT number
- NCT01232062
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-05-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.